the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   4   5   6   7   8   9   10   11   12   13   14   15   Next >>
 
sanofi-aventis: Pipeline, Products, Performance, Potential
Table of Contents Published: 2009/08 Published by: Espicom Business Intelligence
This report provides a full review of the company's activities together with sales forecasts for key products to 2010. ...

OTC Healthcare - United Arab Emirates
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s OTC Healthcare Products in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. ...

Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
Table of Contents Published: 2009/07 Published by: Datamonitor
'Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players' is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies. ...

OTC Healthcare in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
According to official data from the European Commission (based on research of the pharmaceuticals and OTC healthcare markets), the Slovak OTC healthcare market is traditional rather than innovative. ...

World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024
Table of Contents Published: 2009/07 Published by: Visiongain
The global prevalences of AMD (age-related macular degeneration) and diabetic retinopathy are increasing due to rising numbers of older people worldwide. ...

Clinical Trials: World Market 2009-2024
Table of Contents Published: 2009/07 Published by: Visiongain
The market for clinical trials has been expanding rapidly in recent years, with impressive revenue growth and important trends. One regional market expanded by 65% in 2008. From the perspectives of various pharma stakeholders, the expanding clinical resea ...

Wound Treatments in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Wound Treatments in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Eye Care in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Eye Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

NRT Smoking Cessation Aids in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s NRT Smoking Cessation Aids in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Medicated Skin Care in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Medicated Skin Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Digestive Remedies in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold And Allergy (Hay Fever) Remedies in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy (hay Fever) Remedies in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Analgesics in Slovakia
Table of Contents Published: 2009/07 Published by: Euromonitor International
Euromonitor International' s Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ...

Technology Selection: Finally Adding the Actionable to Analytics and Information
Table of Contents Published: 2009/07 Published by: Health Industry Insights
This Health Industry Insights report previews vendor solutions and next-generation business intelligence solution requirements for healthcare payers. ...

United States Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
BMI expects the US pharmaceutical market to contract with a compound annual growth rate (CAGR) of -0.35% during 2008 and 2013 to reach a valuation of US$302bn. ...

Romania Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Romania places sixth among the 20 key markets surveyed as a part of BMI's Pharmaceuticals & Healthcare Business Environment Rankings, and can be found between Turkey and Estonia. ...

Lithuania Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Total drug market expenditure in Lithuania will be affected heavily by the depreciation in local currency against the US dollar. ...

Levothyroxine sodium (CAS 55-03-8) Market Report 2009
Table of Contents Published: 2009/07 Published by: Merchant Research & Consulting LTD.
The study 'Levothyroxine sodium (CAS 55-03-8) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ...

Inflammatory Bowel Disease Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor' s updated forecast will parallel its previous forecast up to 2012, several new product launches, regi ...

Attention-Deficit Hyperactivity Disorder Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. ...

Bayer Schering Pharma AG: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ...

Eli Lilly & Co.: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Eli Lilly in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ...

Novartis AG: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Novartis in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ...

Osteoporosis Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong per ...

Antihormonal Therapies Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the ...

Pricing and Reimbursement: Innovative Risk-Sharing Strategies
Table of Contents Published: 2009/07 Published by: Datamonitor
Novel niche biologics entering the market require high price points in order to provide manufacturers with a return on investment. However, with heightening regulatory scrutiny and increasing cost-pressures, a balance must be struck between incentivizing ...

Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative of a mature market
Table of Contents Published: 2009/07 Published by: Datamonitor
Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. ...

Stakeholder Opinions: Skin and Soft Tissue Infections - The end of the reign of vancomycin
Table of Contents Published: 2009/07 Published by: Datamonitor
Treatment of skin and skin structure infections often requires systemic antibacterial therapy. Two trends are concerning physicians: the spread of methicillin-resistant Staphylococcus aureus (MRSA), particularly community-acquired strains (CA-MRSA) have b ...

Amgen Inc.: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Amgen in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ...

Johnson & Johnson: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ...

Pfizer Inc.: PharmaVitae Profile
Table of Contents Published: 2009/07 Published by: Datamonitor
This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ...

Psoriasis Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
This forecast model shows sales of key products used for the treatment of psoriasis, across the seven major markets. Forecast data to 2018 is psoriasis-specific and can be seen in both value and volume units. ...

Obesity Market Forecast
Table of Contents Published: 2009/07 Published by: Datamonitor
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, re ...

Strategies for Building Early-Stage Pipelines Through External Sources
Table of Contents Published: 2009/07 Published by: Decision Resources, Inc.
Under tremendous pressure to refuel dwindling development pipelines and improve R&D productivity, pharmaceutical companies are seeking external sources of products and innovation. Biotech companies offer valuable technologies, targets, and compounds. Phar ...

Venezuela Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
BMI forecasts a negative US dollar value growth between 2009 and 2013 for Venezuela's drug market, due to the expected economic difficulties in 2009 and 2010. ...

United Kingdom Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In 2008, the UK's drug expenditure reached a value of GPB18.7bn (US$36.8bn) and by 2013, it is expected the drug market will be worth GBP19.3bn (US$32.7bn), equating to a 0.58% compound annual growth rate (CAGR). ...

Russia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 ? most notably as the ruble's managed devaluation earlier in the year did not turn into a rout for the currency, or consume all of the country's stability fund. Still ...

Japan Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In 2009, the value of Japan's pharmaceutical market is expected to only grow marginally, as price cuts and the growth of generic substitution impact pharmaceutical expenditure. ...

Czech Republic Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
The Czech pharmaceutical market is among the most developed in Central and Eastern Europe (CEE). ...

China Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
For the Q309 update of BMI's China Pharmaceuticals & Healthcare report, we have maintained our topline forecast for medicine expenditure in the world's most populous country, as no new sales figures have emerged and the country's macroeconomic projectio ...

Bahrain Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/07 Published by: Business Monitor International
In Q309, BMI expects Bahrainfs total drug market value to increase from US$115mn, in 2008, to US$118mn by 2013, with a compound annual growth rate (CAGR) of only 0.52% in US dollar terms. ...

Data Mining in Drug Development and Translational Medicine Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. ...

Outsourcing Preclinical Studies to China: Benefits and Challenges Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
This report describes the impact that language skills and the shortages of key disciplines have on how best to structure preclinical studies in China. Also evaluated are the broad issues such as IP protection and CRO ownership as well as laboratory animal ...

Competitor Analysis: PI3K-AKT-mTOR Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The report includes a compilation of current active projects in research and development of PI3K-AKT-mTOR inhibitors in oncology and other indications. ...

Competitor Analysis: HDAC Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ...

Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This new benchmarking report frames the current employer market landscape and analyzes how leading companies organize their employer groups, conceive of their efforts, and operate in the field. Managed Care, Managed Markets, and other Sales and Marketing ...

Medical Affairs Resources, Structures and Trends
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top ...

Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Health Outcomes data has become increasingly important to the success of biotechnology and pharmaceutical companies. This study aims to discover and collect best practices in how companies use and review the use of Health Outcomes data in promotional/comm ...

Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This Best Practices, LLC benchmarking report identifies the Market Research structures and activities that best support the Managed Markets function in gaining payer access and insights around pharmaceutical products, as well as captures executives' best ...

The SADC Healthcare Regulatory Environment
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ...


<< Previous Page:   4   5   6   7   8   9   10   11   12   13   14   15   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.